This is a Validated Antibody Database (VAD) review about mouse H2-Eb1, based on 419 published articles (read how Labome selects the articles), using H2-Eb1 antibody in all methods. It is aimed to help Labome visitors find the most suited H2-Eb1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
H2-Eb1 synonym: Eb; H-2Eb; H2Eb; Ia-4; Ia4

BioLegend
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a, 3d
BioLegend H2-Eb1 antibody (BioLegend, 107606) was used in flow cytometry on mouse samples (fig 3a, 3d). Front Immunol (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend H2-Eb1 antibody (BioLegend, 107606) was used in flow cytometry on mouse samples (fig 3a). Sci Adv (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
BioLegend H2-Eb1 antibody (BioLegend, 107627) was used in flow cytometry on mouse samples at 1:200 (fig 3b). Nat Commun (2022) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; 1:100; fig 7a
BioLegend H2-Eb1 antibody (Biolegend, 107617) was used in immunohistochemistry on mouse samples at 1:100 (fig 7a). elife (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2j
BioLegend H2-Eb1 antibody (Biolegend, 107616) was used in flow cytometry on mouse samples (fig 2j). Cell Rep (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; fig 4d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig 4d). Oncotarget (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:500; fig 5g
BioLegend H2-Eb1 antibody (BioLegend, 107607) was used in flow cytometry on mouse samples at 1:500 (fig 5g). Nat Commun (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend H2-Eb1 antibody (Biolegend, 107635) was used in flow cytometry on mouse samples (fig 4c). Oncoimmunology (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig e5f
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig e5f). Nature (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:40; loading ...; fig 4b, s7c
BioLegend H2-Eb1 antibody (BioLegend, 107620) was used in flow cytometry on mouse samples at 1:40 (fig 4b, s7c). J Immunother Cancer (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; loading ...; fig 2, s1
BioLegend H2-Eb1 antibody (Biolegend, 107635) was used in flow cytometry on mouse samples at 1:300 (fig 2, s1). Front Immunol (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; fig 5e
BioLegend H2-Eb1 antibody (Biolegend, 107621) was used in flow cytometry on mouse samples at 1:200 (fig 5e). Brain Pathol (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s20b
BioLegend H2-Eb1 antibody (Biolegend, 107625) was used in flow cytometry on mouse samples (fig s20b). Nat Commun (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6e
BioLegend H2-Eb1 antibody (Biolegend, 107639) was used in flow cytometry on mouse samples at 1:200 (fig 6e). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend H2-Eb1 antibody (Biolegend, 107631) was used in flow cytometry on mouse samples (fig s1a). Cell Rep (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend H2-Eb1 antibody (Biolegend, 107607) was used in flow cytometry on mouse samples (fig s5b). Nat Commun (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend H2-Eb1 antibody (Biolegend, 107613) was used in flow cytometry on mouse samples at 1:100. Nat Nanotechnol (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend H2-Eb1 antibody (BioLegend, 107622) was used in flow cytometry on mouse samples (fig s2e). Sci Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend H2-Eb1 antibody (BioLegend, 107641) was used in flow cytometry on mouse samples (fig s2a). iScience (2021) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (Biolegend, 107613) was used in immunohistochemistry on mouse samples (fig 4a). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend H2-Eb1 antibody (Biolegend, 107618) was used in flow cytometry on mouse samples (fig s5a). PLoS Pathog (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; loading ...
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:400. J Immunother Cancer (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend H2-Eb1 antibody (Biolegend, 107636) was used in flow cytometry on mouse samples (fig s1c). Cell Death Dis (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples at 1:200 (fig 4b). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3e
BioLegend H2-Eb1 antibody (Biolegend, 107626) was used in flow cytometry on mouse samples at 1:200 (fig 3e). Aging Cell (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...
BioLegend H2-Eb1 antibody (BioLegend, 107622) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3i
BioLegend H2-Eb1 antibody (BioLegend, 107605) was used in flow cytometry on mouse samples (fig 3i). Cell Death Dis (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s7c
BioLegend H2-Eb1 antibody (Biolegend, 107605) was used in flow cytometry on mouse samples (fig s7c). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 6c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6c). Front Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend H2-Eb1 antibody (Biolegend, 107621) was used in flow cytometry on mouse samples (fig 2c). Mol Cancer (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human; loading ...; fig 3b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on human samples (fig 3b). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:1000 (fig 2a). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; fig 5a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig 5a). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s4b
BioLegend H2-Eb1 antibody (BioLegend, M5.114. 15.2) was used in immunohistochemistry - frozen section on mouse samples (fig s4b). PLoS Pathog (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human; loading ...; fig s14b
BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on human samples (fig s14b). Commun Biol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:50; loading ...; fig 6a
BioLegend H2-Eb1 antibody (Bioloegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:50 (fig 6a). Front Physiol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a, s2b, s2c
BioLegend H2-Eb1 antibody (Biolegend, 107614) was used in flow cytometry on mouse samples (fig 3a, s2b, s2c). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200
BioLegend H2-Eb1 antibody (Biolegend, 107631) was used in flow cytometry on mouse samples at 1:200. Commun Biol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4d
BioLegend H2-Eb1 antibody (BioLegend, 107625) was used in flow cytometry on mouse samples at 1:200 (fig 4d). Transl Psychiatry (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 11a
BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on mouse samples (fig 11a). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5f). Front Immunol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
BioLegend H2-Eb1 antibody (BioLegend, 107631) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Sci Transl Med (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5f
BioLegend H2-Eb1 antibody (Biolegend, 107620) was used in flow cytometry on mouse samples (fig 5f). Cancer Res (2021) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s2a
BioLegend H2-Eb1 antibody (BioLegend, 107601) was used in immunohistochemistry - frozen section on mouse samples (fig s2a). Sci Adv (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4a, 4b, s4e
BioLegend H2-Eb1 antibody (Biolegend, 107645) was used in flow cytometry on mouse samples (fig 4a, 4b, s4e). Clin Cancer Res (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s12
BioLegend H2-Eb1 antibody (Biolegend, 107606) was used in flow cytometry on mouse samples (fig s12). Sci Rep (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a, 5e
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3a, 5e). Sci Rep (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6). Invest Ophthalmol Vis Sci (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1f). Proc Natl Acad Sci U S A (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, 107613) was used in flow cytometry on mouse samples . J Clin Invest (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:250; loading ...
  • immunohistochemistry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, 107607) was used in flow cytometry on mouse samples at 1:250 and in immunohistochemistry on mouse samples (fig 2a). elife (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4c). Sci Adv (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4c, 6s2e
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4c, 6s2e). elife (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig s6k
BioLegend H2-Eb1 antibody (BioLegend, 107622) was used in flow cytometry on mouse samples at 1:800 (fig s6k). Angiogenesis (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s17
BioLegend H2-Eb1 antibody (BioLegend, 107615) was used in flow cytometry on mouse samples (fig s17). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig 1d). Commun Biol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1f, s2b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1f, s2b). BMC Immunol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2a). Aging Cell (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 4 ug/ml; loading ...; fig s3a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 4 ug/ml (fig s3a). Science (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2c). J Virol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
BioLegend H2-Eb1 antibody (BioLegend, 107626) was used in flow cytometry on mouse samples at 1:400 (fig 3a). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s6c, s9
BioLegend H2-Eb1 antibody (Biolegend, 107631) was used in flow cytometry on mouse samples at 1:100 (fig s6c, s9). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s20a
BioLegend H2-Eb1 antibody (Biolegend, 107625) was used in flow cytometry on mouse samples at 1:100 (fig s20a). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2c). Sci Adv (2019) ncbi
rat monoclonal (M5/114.15.2)
  • mass cytometry; mouse; 0.75 ug/ml; loading ...; fig 5d
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in mass cytometry on mouse samples at 0.75 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3c, 5d, s3b, s7c
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples (fig 3c, 5d, s3b, s7c). Cell Rep (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:500; fig s2
BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on mouse samples at 1:500 (fig s2). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig e10a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig e10a). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2s2a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.14.2) was used in flow cytometry on mouse samples (fig 2s2a). elife (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s3h
BioLegend H2-Eb1 antibody (BioLegend, 107622) was used in flow cytometry on mouse samples (fig s3h). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3b, 4b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3b, 4b). Biomolecules (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 4d, 8h
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples at 1:400 (fig 4d, 8h). Nat Commun (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend H2-Eb1 antibody (BioLegend, 107637) was used in flow cytometry on mouse samples (fig s1c). Cell (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend H2-Eb1 antibody (Biolegend, 107623) was used in flow cytometry on mouse samples (fig 1a). Oncoimmunology (2019) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig ex4o
BioLegend H2-Eb1 antibody (BioLegend, 107608) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig ex4o). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend H2-Eb1 antibody (BioLegend, 107636) was used in flow cytometry on mouse samples (fig 3a). Immunity (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, 107622) was used in flow cytometry on mouse samples at 1:800 (fig 2a). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.152) was used in flow cytometry on mouse samples (fig s1d). J Clin Invest (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 7c
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 7c). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples (fig 3b). Cell (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5g
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5g). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s3e
BioLegend H2-Eb1 antibody (BioLegend, 107617) was used in flow cytometry on mouse samples (fig s3e). Cell (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples (fig 1e). Cell (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 5 ug/ml; loading ...; fig s12
BioLegend H2-Eb1 antibody (BioLegend, 107620) was used in flow cytometry on mouse samples at 5 ug/ml (fig s12). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples (fig 2a). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6s2
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig 6s2). elife (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, M5) was used in flow cytometry on mouse samples (fig 2a). Biochem Biophys Res Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BioLegend H2-Eb1 antibody (Biolegend, 107614) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Neurochem Int (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s19b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s19b). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend H2-Eb1 antibody (Biolegend, 107628) was used in flow cytometry on mouse samples (fig 2e). Cell Rep (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples (fig s1). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; loading ...; fig s9a, s9b
BioLegend H2-Eb1 antibody (BioLegend, M5/114) was used in flow cytometry on mouse samples at 1:300 (fig s9a, s9b). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.152) was used in flow cytometry on mouse samples (fig s8a). JCI Insight (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; loading ...; fig 3c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in immunohistochemistry on mouse samples (fig 3c). J Immunol (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s3d
BioLegend H2-Eb1 antibody (BioLegend, 107630) was used in flow cytometry on mouse samples (fig s3d). Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s9b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s9b). Science (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2e
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2e). J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1b). J Clin Invest (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1c). J Immunol Res (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig s4
BioLegend H2-Eb1 antibody (Biolegend, 107645) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig s4). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5b). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.152) was used in flow cytometry on mouse samples (fig 2b). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, M5/114) was used in flow cytometry on mouse samples (fig 2a). PLoS ONE (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human; loading ...; fig s1a
BioLegend H2-Eb1 antibody (Biolegend, 107630) was used in flow cytometry on human samples (fig s1a). Immunity (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s3c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s3c). J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig s1a). Oncoimmunology (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3g). Nat Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). Int J Obes (Lond) (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2a). J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend H2-Eb1 antibody (Biolegend, 107628) was used in flow cytometry on mouse samples (fig 2e). Mol Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, 107620) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s3). Eur J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend H2-Eb1 antibody (Biolegend, 107607) was used in flow cytometry on mouse samples (fig s1a). Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s8a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig s8a). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1a). Cell Metab (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; loading ...; fig s4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:400 (fig s4a). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s2a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s2a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 4a
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig 4a). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s3b). J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
BioLegend H2-Eb1 antibody (BioLegend, M5/ 114.15.2) was used . Immunohorizons (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s3a
BioLegend H2-Eb1 antibody (BioLegend, 107631) was used in flow cytometry on mouse samples (fig s3a). Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 1e
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 1e). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 9b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 9b). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - free floating section; mouse; 1:100; loading ...; fig 4c
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in immunohistochemistry - free floating section on mouse samples at 1:100 (fig 4c) and in flow cytometry on mouse samples (fig 4a). Exp Neurol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 1a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig 1a). FASEB J (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; fig s6g
BioLegend H2-Eb1 antibody (BD Biosciences, 107614) was used in flow cytometry on mouse samples at 1:200 (fig s6g). Nat Cell Biol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . Diabetologia (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2a). Eur J Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1b
In order to study the involvement of endocannabinoid system in intestinal immune homeostasis, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). Nat Med (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s5b, s5d
In order to demonstrate that type 1 T helper cells play a crucial role in vessel normalization, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s5b, s5d). Nature (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). Immunology (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to compare human and mouse BCMA expression, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s6
In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on mouse samples (fig s6). Mol Cell (2017) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3d
In order to find that activin-follistatin regulation may play a role during the development of experimental autoimmune epididymo-orchitis, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3d). Sci Rep (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig S5
In order to find that C-type lectin dendritic cell immunoreceptor is required to modulate lung inflammation and bacterial burden in tuberculosis, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig S5). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
  • immunocytochemistry; mouse; loading ...; fig 6
In order to explain several useful methods to characterize not only DCs but also other immune cells in steady state and atherosclerotic aorta, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3a) and in immunocytochemistry on mouse samples (fig 6). Methods Mol Biol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend H2-Eb1 antibody (BioLegend, 107626) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:160; loading ...; fig 5d
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, BioLegend H2-Eb1 antibody (Biolegend, 107606) was used in flow cytometry on mouse samples at 1:160 (fig 5d). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). PLoS ONE (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to characterize Aire-mediated signaling in medullary thymic epithelial cells, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1a). Nat Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3d). Cancer Res (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s2a
In order to suggest that air-pollution-induced atopic dermatitis occurs through activation of AhR, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s2a). Nat Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5d). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2f
In order to explore how apoptotic intestinal epithelial cells are processed and sampled, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2f). Nature (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to show that R848-mediated suppression of experimental asthma is IL-27-dependent, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5a
In order to use a humanized mouse model to study Middle East respiratory syndrome coronavirus, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5a). J Virol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Oncotarget (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study the role of PU.1 in the expression of OX40L in dendritic cells, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s4e
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s4e). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; tbl 1
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples at 1:800 (tbl 1). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1b
In order to examine the origin and regulatory factors that maintain MHC II positive peritoneal and pleural macrophages, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3c). Oncogene (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2c
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2c). J Clin Invest (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...
In order to explore the relationships among beta8 integrin, TGF-beta, and intestinal dendritic cells, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s6b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s6b). Nat Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; fig 3
BioLegend H2-Eb1 antibody (BioLegend, 107614) was used in flow cytometry on mouse samples at 1:200 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s3
In order to characterize the cellular basis and dynamics of the inflammatory microenvironment present in glioblastomas multiforme, BioLegend H2-Eb1 antibody (Biolegend/Ozyme, M5/114.15.2) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4k
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4k). Nature (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
In order to analyze the determinant of dendritic cell trafficking through the CCR7-CCL19/21 axis by graft site microenvironment, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Invest Ophthalmol Vis Sci (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2b, 1d
In order to report that the maternal microbiota shapes the offspring's immune system, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2b, 1d). Science (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2d). Gastroenterology (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s12
In order to study the response of intestinal tuft cells to parasites, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s12). Science (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 10k
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 10k). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human; 1:20; fig 2
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1
In order to research the role of Tim-1 and Tim-4 blockade in the atherosclerotic pathogenesis, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). Arterioscler Thromb Vasc Biol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
In order to study dendritic cells in Sirt6 knock out mice, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1). Aging (Albany NY) (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2J
In order to determine that Th2 cell responses, alternative macrophage activation, and immunoglobulin class switching to IgG1, are enhanced in Batf3(-/-) mice responding to helminth parasites, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2J). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
BioLegend H2-Eb1 antibody (biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). Nat Med (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
In order to study apolipoprotein-1 during normocholesterolemic conditions, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4b
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4b). Mucosal Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . Mucosal Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, (M5/114, 15, 2) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, 107635) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4d). J Exp Med (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; fig 4
BioLegend H2-Eb1 antibody (BioLegend, 107621) was used in immunohistochemistry on mouse samples (fig 4). J Virol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; fig 2
BioLegend H2-Eb1 antibody (Biolegend, 107622) was used in flow cytometry on mouse samples at 1:300 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to assess the capacity of dried microneedle array vaccination on effector/memory CD8 positive T cell subsets, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). Vaccine (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
BioLegend H2-Eb1 antibody (BioLegend, M5/114.152) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s4
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s4). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; hamsters; fig 7
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on hamsters samples (fig 7). J Virol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s5
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s5). PLoS Pathog (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; tbl s3
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
mouse monoclonal (14-4-4S)
  • flow cytometry; rat; fig s3a
  • flow cytometry; mouse; fig s3a
BioLegend H2-Eb1 antibody (BioLegend, 14-4-4S) was used in flow cytometry on rat samples (fig s3a) and in flow cytometry on mouse samples (fig s3a). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; fig 5
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples (fig 5). PLoS Pathog (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
In order to investigate the effect of IL-7 and anti-PD-1 treatment in sepsis model followed by Candida albicans infection, BioLegend H2-Eb1 antibody (Biolegend, 107626) was used in flow cytometry on mouse samples (fig 2). Shock (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
BioLegend H2-Eb1 antibody (Biolegend, clone M5/114.15.2) was used in flow cytometry on mouse samples (fig 1). Eur J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
BioLegend H2-Eb1 antibody (Biolegend, M5/ 114.15.2) was used in flow cytometry on mouse samples (fig 5). J Heart Lung Transplant (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Mol Pharmacol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3.26.3
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3.26.3). Curr Protoc Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2). Nat Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to assess the contribution of Tbx1 to thymus and parathyroid development, BioLegend H2-Eb1 antibody (BioLegend, clone M5/114.15.2) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2014) ncbi
rat monoclonal (M5/114.15.2)
BioLegend H2-Eb1 antibody (BioLegend, 107627) was used . J Neurosci (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (M5/114.15.2)
BioLegend H2-Eb1 antibody (BioLegend, 107602) was used . PLoS ONE (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 6b
In order to test if pharmacological modulation of SPPL2a can deplete B cells, BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6b). Mol Cell Biol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
BioLegend H2-Eb1 antibody (Biolegend, M5/114/15/2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend H2-Eb1 antibody (BioLegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4c). J Leukoc Biol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3c
BioLegend H2-Eb1 antibody (Biolegend, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3c). PLoS ONE (2013) ncbi
Invitrogen
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen H2-Eb1 antibody (eBioscience, 17-5321-81) was used in flow cytometry on mouse samples (fig 6a). Arthritis Res Ther (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s1d
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples at 1:200 (fig s1d). Immunity (2022) ncbi
rat monoclonal (M5/114.15.2)
  • immunocytochemistry; mouse; loading ...
Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-82) was used in immunocytochemistry on mouse samples . J Clin Invest (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6e
Invitrogen H2-Eb1 antibody (Invitrogen, 48-5321-82) was used in flow cytometry on mouse samples (fig 6e). J Immunother Cancer (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5g
Invitrogen H2-Eb1 antibody (eBioscience, M5114.15.2) was used in flow cytometry on mouse samples (fig 5g). Int J Mol Sci (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; loading ...; fig 4d, s2a, s2d
Invitrogen H2-Eb1 antibody (Thermo Fisher, M5/114.15.2) was used in flow cytometry on mouse samples at 1:400 (fig 4d, s2a, s2d). Immunol Cell Biol (2022) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a, s1
Invitrogen H2-Eb1 antibody (eBioscience, 47-5321-82) was used in flow cytometry on mouse samples (fig 2a, s1). Front Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s10a
Invitrogen H2-Eb1 antibody (eBioscience, 25-5321-82) was used in flow cytometry on mouse samples (fig s10a). Front Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). Aging Dis (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen H2-Eb1 antibody (Ebioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4b). Front Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1d, 3f
Invitrogen H2-Eb1 antibody (eBioscience/Thermo Scientific, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1d, 3f). Mucosal Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...
Invitrogen H2-Eb1 antibody (eBioscience, M5/11.415.2) was used in flow cytometry on mouse samples . Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 0.05 ug/ml; loading ...; fig 8b
Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in flow cytometry on mouse samples at 0.05 ug/ml (fig 8b). Basic Res Cardiol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Reprod Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2). Sci Rep (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s21
Invitrogen H2-Eb1 antibody (eBioscience, 46-5321-82) was used in flow cytometry on mouse samples (fig s21). Nat Commun (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2b, s2d
Invitrogen H2-Eb1 antibody (eBioscience, 15-5321-81) was used in flow cytometry on mouse samples (fig s2b, s2d). Sci Adv (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4a). Mucosal Immunol (2021) ncbi
rat monoclonal (M5/114.15.2)
Invitrogen H2-Eb1 antibody (eBiosciences, 48-5321-82) was used . Aging Cell (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig 2s1a
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples at 1:800 (fig 2s1a). elife (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:1200; loading ...; fig 4s1
Invitrogen H2-Eb1 antibody (eBioscience, 17-5321) was used in flow cytometry on mouse samples at 1:1200 (fig 4s1). elife (2020) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 1b
Invitrogen H2-Eb1 antibody (Thermofisher, 14-5321-82) was used in immunohistochemistry on mouse samples at 1:250 (fig 1b). Front Neurosci (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human; 1:100; loading ...; fig 7b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on human samples at 1:100 (fig 7b). Front Immunol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; loading ...; fig s7a
Invitrogen H2-Eb1 antibody (Invitrogen, 67-5321-82) was used in flow cytometry on mouse samples at 1:300 (fig s7a). Cell Res (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig s9
Invitrogen H2-Eb1 antibody (eBioscience, 25-5321-80) was used in flow cytometry on mouse samples at 1:100 (fig s9). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Acta Neuropathol (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; fig s15c
Invitrogen H2-Eb1 antibody (Thermo Fisher, 48-5321-80) was used in flow cytometry on mouse samples at 1:800 (fig s15c). Nat Commun (2020) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
Invitrogen H2-Eb1 antibody (eBioscience, 46532182) was used in flow cytometry on mouse samples at 1:200 (fig 4b). Nat Commun (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig e10
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:80; loading ...; fig s3g
Invitrogen H2-Eb1 antibody (eBioscience, 47- 5321-82) was used in flow cytometry on mouse samples at 1:80 (fig s3g). Nat Commun (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen H2-Eb1 antibody (ThermoFisher Scientific, 47-5321-82) was used in flow cytometry on mouse samples (fig 4f). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2f
Invitrogen H2-Eb1 antibody (Thermo Fisher, 14-5321) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2f). FASEB J (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; loading ...; fig s3b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:300 (fig s3b). J Clin Invest (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2h
Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-81) was used in flow cytometry on mouse samples (fig 2h). Sci Rep (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4e, 4k, 4l
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples (fig 4e, 4k, 4l). Nature (2019) ncbi
rat monoclonal (M5/114.15.2)
  • western blot; mouse; 1:200; loading ...; fig s17a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in western blot on mouse samples at 1:200 (fig s17a). Science (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen H2-Eb1 antibody (eBioscience, 47-5321-82) was used in flow cytometry on mouse samples (fig 1b). Immunity (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3e). Glia (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s5a, s5b
Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in flow cytometry on mouse samples (fig s5a, s5b). Cell Rep (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5f
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:100 (fig 5f). J Pathol (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1a). Blood (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig ev2c
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig ev2c). EMBO J (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen H2-Eb1 antibody (Thermo Fisher, 56-5321-82) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen H2-Eb1 antibody (Thermo Fisher Scientific, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s7i
Invitrogen H2-Eb1 antibody (eBiosciences, 25-5321-82) was used in flow cytometry on mouse samples at 1:200 (fig s7i). Nat Neurosci (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1a
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples (fig 1a) and in flow cytometry on mouse samples (fig 3d). J Neuroinflammation (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples (fig 2a). Cell Rep (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5e
Invitrogen H2-Eb1 antibody (Biolegend, 14-5321-81) was used in immunohistochemistry on mouse samples at 1:50 (fig 5e). J Clin Invest (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig e5d
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig e5d). Nature (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:150; loading ...; fig s6a
Invitrogen H2-Eb1 antibody (eBioscience, 17-5321-82) was used in flow cytometry on mouse samples at 1:150 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen H2-Eb1 antibody (Thermofisher Scientific, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2b). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s4a
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig s4a). PLoS ONE (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3e). J Exp Med (2018) ncbi
rat monoclonal (M5/114.15.2)
  • western blot; mouse; loading ...; fig 5f
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in western blot on mouse samples (fig 5f). Front Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; fig s1a
  • flow cytometry; mouse; fig 1a
Invitrogen H2-Eb1 antibody (eBiosciences, 11-5321-85) was used in immunohistochemistry - frozen section on mouse samples (fig s1a) and in flow cytometry on mouse samples (fig 1a). Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig 1a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:800 (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6a). J Immunol (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1a). Science (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 7c
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples (fig 7c). EMBO J (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s5c
Invitrogen H2-Eb1 antibody (Thermo Fisher Scientific, 17-5321-82) was used in flow cytometry on mouse samples (fig s5c). Cell (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2a). Cancer Res (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5a
In order to study the role of non-classical MHC Class II gene H2-Ob in the immune response towards viral infection, Invitrogen H2-Eb1 antibody (eBiosciences, 17-5321-82) was used in flow cytometry on mouse samples (fig 5a). Immunity (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6a). Front Cell Infect Microbiol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of IL-4Ralpha-mediated macrophage activation promote in lung and liver wound repair, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 6a
In order to investigate the efficacy of codelivering engineered T cells and STING agonists in cancer therapy, Invitrogen H2-Eb1 antibody (eBiosciences, 12-5321-81) was used in flow cytometry on mouse samples (fig 6a). J Clin Invest (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5d). J Leukoc Biol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3a
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3a). Int J Parasitol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 7d
In order to determine the role of RelB in classical dendritic cell and myeloid development, Invitrogen H2-Eb1 antibody (eBioscience, M5/114/15/2) was used in flow cytometry on mouse samples (fig 7d). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (14-4-4S)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s2a
In order to propose that macrophage-TNF-induced AKT/beta-catenin signaling in Lgr5(+) hair follicle stem cells is important for promoting hair follicle cycling and neogenesis after wounding, Invitrogen H2-Eb1 antibody (eBioscience, 14-4-4S) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s2a). Nat Commun (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:50; loading ...; fig 9a
In order to study the immune responses in mice infected with GFP-expressing Rickettsia typhi, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:50 (fig 9a). Infect Immun (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig s1a
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, Invitrogen H2-Eb1 antibody (eBioscience, M5) was used in flow cytometry on mouse samples at 1:800 (fig s1a). Nat Commun (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to examine the localization and function of FHL2 in natural killer cells, Invitrogen H2-Eb1 antibody (Affymetrix eBioscience, M5/114) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3c
In order to study the D. farinae allergen Pplase in a mouse model., Invitrogen H2-Eb1 antibody (Ebioscience, 11-5321) was used in flow cytometry on mouse samples (fig 3c). Sci Rep (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:500; loading ...; fig 6c
In order to examine two llama-derived single-domain respiratory syncytial virus neutralizing antibodies, Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in flow cytometry on mouse samples at 1:500 (fig 6c). Nat Commun (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3a
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen H2-Eb1 antibody (eBioscience, 125-5321) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3b
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Invitrogen H2-Eb1 antibody (eBioscience, 17-5321) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2a
In order to identify myeloid cells obtained from mouse intestine., Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in flow cytometry on mouse samples (fig 2a). Methods Mol Biol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; fig s3
In order to observe that cardiac myofibroblasts efficiently engulf dead cells, Invitrogen H2-Eb1 antibody (eBiosciences, 46-5321-80) was used in flow cytometry on mouse samples at 1:200 (fig s3). J Clin Invest (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
In order to determine the function of intraluminal migration of CX3CR1 positive cells in the intestine, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5). J Immunol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 2.5 ug/ml; loading ...; fig 5
In order to develop an in vivo approach using intracerebral grafting of mesenchymal stem cells to secrete interleukin 13, Invitrogen H2-Eb1 antibody (eBioscience, 14-5321-82) was used in immunohistochemistry - frozen section on mouse samples at 2.5 ug/ml (fig 5). J Neuroinflammation (2016) ncbi
rat monoclonal (M5/114.15.2)
  • blocking or activating experiments; mouse; loading ...
In order to image endosomal transferrin receptors in B-lymphocytes., Invitrogen H2-Eb1 antibody (eBioscience, 12-5321) was used in blocking or activating experiments on mouse samples . Opt Express (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3e
In order to study the role of miR-7 in acute lung injury, Invitrogen H2-Eb1 antibody (ebioscience, 12-5321-81) was used in flow cytometry on mouse samples (fig 3e). Front Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, Invitrogen H2-Eb1 antibody (eBiosciences, 25-5321-82) was used in flow cytometry on mouse samples (fig st2). Nature (2016) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5a
In order to show that the administration of IL-13 is protective in the cuprizone mouse model for multiple sclerosis, Invitrogen H2-Eb1 antibody (eBioscience, 14-5321-82) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5a). Glia (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:300; loading ...
In order to characterize Tnip1-deficient mice as a model for psoriasis, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:300. Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1j
In order to establish and characterize a mouse model of narcolepsy, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1j). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5e
In order to report that GM-CSF contributes to cardiac disease in a mouse model of Kawasaki disease, Invitrogen H2-Eb1 antibody (eBioscience, M5/114) was used in immunohistochemistry - frozen section on mouse samples (fig 5e). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; tbl 1
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples at 1:800 (tbl 1). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:800; loading ...; fig 1a
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:800 (fig 1a). PLoS ONE (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3b
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s1
In order to test if a diet high in fats affects the development of respiratory tolerance, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). PLoS ONE (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3b). J Leukoc Biol (2017) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2b). Immunity (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
In order to develop a protocol for differentiation of retinal pigment epithelium from mouse induced pluripotent stem cells, Invitrogen H2-Eb1 antibody (eBioscience, 11-5321) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1-s1
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen H2-Eb1 antibody (eBiosciences, 13-5321-85) was used in flow cytometry on mouse samples (fig 1-s1). elife (2016) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5c
In order to characterize the cellular basis and dynamics of the inflammatory microenvironment present in glioblastomas multiforme, Invitrogen H2-Eb1 antibody (Ebiosciences, 145321) was used in immunohistochemistry on mouse samples at 1:50 (fig 5c). Sci Rep (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s4
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s4). Sci Rep (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
In order to study promotion of host immunity and protection against IL-12/23p40-dependent lung injury during hookworm infection by myeloid-restricted AMPK-alpha1, Invitrogen H2-Eb1 antibody (eBioscience, M5-114.15.2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-82) was used in flow cytometry on mouse samples (fig s1). Leukemia (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:400; fig s3
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen H2-Eb1 antibody (eBioscience, 17-5321-81) was used in flow cytometry on mouse samples at 1:400 (fig s3). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2i
In order to test if heme oxygenase-1 mediates cardiac protection by altering mitochondrial quality control, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2i). JCI Insight (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 3h
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3h). J Exp Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s7
In order to characterize promotion of an effective anti-tumor immune response by enhancing the production of type 1 interferons by 2'-5' oligoadenylate synthetase-like 1 (OASL1) deficiency in mice, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s7). Cancer Immunol Immunother (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321) was used in flow cytometry on mouse samples (fig 3). Int J Mol Med (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2b
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2b). J Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
Invitrogen H2-Eb1 antibody (eBioscience, 56-5321-82) was used in flow cytometry on mouse samples (fig 4). Sci Rep (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS Pathog (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2). Microbes Infect (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS Pathog (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:500
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples at 1:500. Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-80) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2d
In order to present the role of Blimp-1 on plasma cell function via regulation of immunoglobulin secretion and the unfolded protein response, Invitrogen H2-Eb1 antibody (eBiosciences, M5) was used in flow cytometry on mouse samples (fig 2d). Nat Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - paraffin section; mouse; fig 2
Invitrogen H2-Eb1 antibody (eBioscience, 13-5321-81) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Lab Invest (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; tbl s6
In order to characterize and determine the origin of arterial macrophages, Invitrogen H2-Eb1 antibody (eBiosciences, 56-5321-82) was used in flow cytometry on mouse samples (tbl s6). Nat Immunol (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2e
Invitrogen H2-Eb1 antibody (eBiosciences, M5 1114.15.2) was used in flow cytometry on mouse samples (fig s2e). Nat Med (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - free floating section; mouse; 1:100; fig 1
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in immunohistochemistry - free floating section on mouse samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; fig s3
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples (fig s3). PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 2c, d
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 2c, d). Eur J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 5b
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5b). Nat Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; fig s1
In order to investigate the role of dendritic cells in the hypothalamic pituitary adrenal axis, Invitrogen H2-Eb1 antibody (eBioscience, 14-5321-32) was used in immunohistochemistry - frozen section on mouse samples (fig s1). Brain Behav Immun (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-83) was used in flow cytometry on mouse samples (fig 1). Cancer Res (2015) ncbi
rat monoclonal (M5/114.15.2)
  • western blot; mouse
Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in western blot on mouse samples . J Vis Exp (2015) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
In order to investigate the mechanisms that regulate the entrance and exit of immune cells from the central nervous system, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). Nature (2015) ncbi
rat monoclonal (M5/114.15.2)
  • western blot; human; 1:2000
In order to report that MET is required for neutrophil chemoattraction and cytotoxicity in response to its ligand hepatocyte growth factor, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15-12) was used in western blot on human samples at 1:2000. Nature (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s1f
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1f). PLoS ONE (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human
  • flow cytometry; mouse
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen H2-Eb1 antibody (eBioscience, 11- 5321-81) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Cancer Res (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
Invitrogen H2-Eb1 antibody (eBioscience (Affymetrix), M5/144.15.2) was used in flow cytometry on mouse samples (fig 4). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 2
Invitrogen H2-Eb1 antibody (eBiosciences, M5-114) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s1
  • immunohistochemistry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1) and in immunohistochemistry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig S7
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen H2-Eb1 antibody (eBioscience, 11-5332) was used in flow cytometry on mouse samples (fig S7). Nat Biotechnol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . Hum Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s1
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:500
Invitrogen H2-Eb1 antibody (eBioscience, 11-5321-81) was used in flow cytometry on mouse samples at 1:500. Neuro Oncol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1b
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, Invitrogen H2-Eb1 antibody (ebioscience, M5/114) was used in flow cytometry on mouse samples (fig 1b). Nat Commun (2014) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen H2-Eb1 antibody (eBioscience, M5/114) was used in immunohistochemistry on mouse samples . Immunology (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
In order to describe the pathogenesis of influenza A virus and Sendai virus in ISG15 knockout mice, Invitrogen H2-Eb1 antibody (eBioscience, 114.15.2) was used in flow cytometry on mouse samples (fig 5). J Virol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2a
In order to investigate the effect of ADAM17 on CSF1R protein expression on hematopoietic progenitors, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2a). Exp Hematol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 6
In order to determine the role of Foxm1 in bronchopulmonary dysplasia-associated pulmonary inflammation, Invitrogen H2-Eb1 antibody (eBiosciences, clone M5/114.15.2) was used in flow cytometry on mouse samples (fig 6). Am J Respir Cell Mol Biol (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, 48-5321-82) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (M5/114.15.2)
  • immunocytochemistry; mouse; 1:200
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in immunocytochemistry on mouse samples at 1:200. Invest Ophthalmol Vis Sci (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human
  • immunocytochemistry; human
Invitrogen H2-Eb1 antibody (eBioscience, 17-5321-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
Invitrogen H2-Eb1 antibody (Ebioscience, 15-5321-82) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100
Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-82) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
In order to characterize tumor-associated macrophages isolated from gastrointestinal stromal tumors, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4). J Exp Med (2013) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . Diabetes (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
Invitrogen H2-Eb1 antibody (ebioscience, M5.114.15.2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:100
Invitrogen H2-Eb1 antibody (eBioscience, 11-5321-81) was used in flow cytometry on mouse samples at 1:100. Nat Med (2013) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
In order to identify CD11b(+) classical dendritic cells as the source of IL-23 in C. rodentium infected mice, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2013) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig s2
In order to generate and characterize Hoxb8-FL cells, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig s2). Nat Methods (2013) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 6b
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6b). PLoS ONE (2013) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3
Invitrogen H2-Eb1 antibody (e-Biosciences,, 11-5321-81) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - frozen section; human
Invitrogen H2-Eb1 antibody (eBioscience, 14-5321) was used in immunohistochemistry - frozen section on human samples . PLoS ONE (2012) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human
In order to review cellular and molecular mechanisms that contribute to chronic obstructive pulmonary disease pathogenesis, Invitrogen H2-Eb1 antibody (eBiosciences, M5/144.15.2) was used in flow cytometry on human samples . PLoS ONE (2011) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
In order to compare pro-Th2 DCs to pro-Th1 DCs, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples . J Proteomics (2012) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 3
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.115.2) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2011) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 5
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 5). J Immunol (2010) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
  • immunocytochemistry; mouse; fig 7
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen H2-Eb1 antibody (eBiosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 1) and in immunocytochemistry on mouse samples (fig 7). Infect Immun (2010) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
rat monoclonal (M5/114.15.2)
  • western blot; human
Invitrogen H2-Eb1 antibody (eBioscience, ME/114.15.2) was used in western blot on human samples . J Immunol (2009) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 7
In order to investigate how lymphocytes traffic between the peritoneal cavity and omentum, Invitrogen H2-Eb1 antibody (eBioscience, 11-5321-85) was used in flow cytometry on mouse samples (fig 7). J Immunol (2009) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 4
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
In order to investigate the immunological mechanism leading to rejection of allogeneic bone marrow-derived stromal cells after implantation in murine central nervous system, Invitrogen H2-Eb1 antibody (eBioscience, 12-5321) was used in flow cytometry on mouse samples (fig 1). Immunol Cell Biol (2009) ncbi
rat monoclonal (M5/114.15.2)
  • immunocytochemistry; mouse
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in immunocytochemistry on mouse samples . Cell Host Microbe (2009) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 1
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen H2-Eb1 antibody (eBioscience, MS/114.15.2) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2008) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; fig 6
In order to employ a intraperitoneal drug delivery system for systemic cancer immunotherapy employing ovalbumin as a model antigen, Invitrogen H2-Eb1 antibody (e-Bioscience, M5/114.15.2) was used in flow cytometry on mouse samples (fig 6). Cancer Lett (2008) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry; mouse
In order to describe the novel junctions between endothelial cells of initial lymphatics, Invitrogen H2-Eb1 antibody (eBioscience, M5/115.14.2) was used in immunohistochemistry on mouse samples . J Exp Med (2007) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
In order to suggest that the enzyme IDO is more highly expressed in nonplasmacytoid dendritic cells of the nose draining lymph nodes, Invitrogen H2-Eb1 antibody (eBioscience, M5/114) was used in flow cytometry on mouse samples . J Immunol (2007) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse
In order to examine the origin and development of Aire positive medullary thymic epithelial cells, Invitrogen H2-Eb1 antibody (eBioscience, 114.15.2) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
rat monoclonal (M5/114.15.2)
  • immunohistochemistry - paraffin section; rat
In order to test if renal stem cells exist in the adult kidney and participate in the acute injury repair, Invitrogen H2-Eb1 antibody (eBioscience, 12-5321-81) was used in immunohistochemistry - paraffin section on rat samples . J Am Soc Nephrol (2006) ncbi
rat monoclonal (M5/114.15.2)
  • other; mouse; 1:10
  • flow cytometry; mouse; 1:10
In order to examine the roles of macrophage galactose-type C-type lectin 1 and 2 expressing cells during inflammation, Invitrogen H2-Eb1 antibody (eBioscience, M5/114/15.2) was used in other on mouse samples at 1:10 and in flow cytometry on mouse samples at 1:10. Int Immunol (2005) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; human
  • flow cytometry; mouse; fig 5
Invitrogen H2-Eb1 antibody (eBioscience, M5/114.15.2) was used in flow cytometry on human samples and in flow cytometry on mouse samples (fig 5). J Immunol (2005) ncbi
Tonbo Biosciences
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig ds1a
Tonbo Biosciences H2-Eb1 antibody (Tonbo, 35-5321) was used in flow cytometry on mouse samples (fig ds1a). Cell Rep (2021) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 1a
Tonbo Biosciences H2-Eb1 antibody (Tonbo, 80-5321) was used in flow cytometry on mouse samples (fig 1a). Cell (2019) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig s1b
Tonbo Biosciences H2-Eb1 antibody (Tonbo Biosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig s1b). Science (2018) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; 1:200; loading ...; fig s4b
Tonbo Biosciences H2-Eb1 antibody (Tonbo Biosciences, M5/114.15.2) was used in flow cytometry on mouse samples at 1:200 (fig s4b). Nat Commun (2016) ncbi
rat monoclonal (M5/114.15.2)
  • flow cytometry; mouse; loading ...; fig 4d
In order to analyze the effects of beta-lactam-plus-macrolide therapy using a lethal pneumococcal pneumonia mouse infection model, Tonbo Biosciences H2-Eb1 antibody (Tonbo Biosciences, M5/114.15.2) was used in flow cytometry on mouse samples (fig 4d). Antimicrob Agents Chemother (2016) ncbi
Articles Reviewed
  1. Zhao F, Zhang C, Li G, Zheng H, Gu L, Zhou H, et al. A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. Front Immunol. 2022;13:873720 pubmed publisher
  2. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  3. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed publisher
  4. Burl R, Rondini E, Wei H, Pique Regi R, Granneman J. Deconstructing cold-induced brown adipocyte neogenesis in mice. elife. 2022;11: pubmed publisher
  5. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  6. Zhang L, Zheng D, Yan Y, Yu Y, Chen R, Li Z, et al. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis Res Ther. 2022;24:148 pubmed publisher
  7. Tran C, Scurr M, O Connor L, Buzzelli J, Ng G, Chin S, et al. IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells. Oncotarget. 2022;13:785-799 pubmed publisher
  8. Wang Q, Bergholz J, Ding L, Lin Z, Kabraji S, Hughes M, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022 pubmed publisher
  9. Liu Y, Deguchi Y, Wei D, Liu F, Moussalli M, Deguchi E, et al. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nat Commun. 2022;13:2665 pubmed publisher
  10. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  11. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  12. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  13. Abbas Z, GEORGE C, Ancliffe M, Howlett M, Jones A, Kuchibhotla M, et al. Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets. Front Immunol. 2022;13:837013 pubmed publisher
  14. Ziaei A, Garcia Miralles M, Radulescu C, Sidik H, Silvin A, Bae H, et al. Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult. Brain Pathol. 2022;32:e13064 pubmed publisher
  15. Zhang M, Cui J, Lee D, Yuen V, Chiu D, Goh C, et al. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nat Commun. 2022;13:954 pubmed publisher
  16. Simpson D, Pang J, Weir A, Kong I, Fritsch M, Rashidi M, et al. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity. 2022;55:423-441.e9 pubmed publisher
  17. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  18. Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, et al. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer. 2022;10: pubmed publisher
  19. Wolpaw A, Grossmann L, Dessau J, Dong M, Aaron B, Brafford P, et al. Epigenetic state determines inflammatory sensing in neuroblastoma. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher
  20. Osokine I, Siewiera J, Rideaux D, Ma S, Tsukui T, Erlebacher A. Gene silencing by EZH2 suppresses TGF-β activity within the decidua to avert pregnancy-adverse wound healing at the maternal-fetal interface. Cell Rep. 2022;38:110329 pubmed publisher
  21. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  22. Clayer E, Frank D, Anderton H, Zhang S, Kueh A, Heim V, et al. ZC3H12C expression in dendritic cells is necessary to prevent lymphadenopathy of skin-draining lymph nodes. Immunol Cell Biol. 2022;100:160-173 pubmed publisher
  23. Du Y, Peng Q, Cheng D, Pan T, Sun W, Wang H, et al. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun. 2022;13:231 pubmed publisher
  24. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  25. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  26. Fearon A, Slabber C, Kuklin A, Bachofner M, Tortola L, Pohlmeier L, et al. Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis. iScience. 2021;24:103143 pubmed publisher
  27. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  28. Snyder L, Doherty C, Mercer H, Denkers E. Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade. PLoS Pathog. 2021;17:e1009970 pubmed publisher
  29. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  30. Tian N, Hu L, Lu Y, Tong L, Feng M, Liu Q, et al. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis. Cell Death Dis. 2021;12:853 pubmed publisher
  31. Yang C, Lei L, Collins J, Briones M, Ma L, Sturdevant G, et al. Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor. Nat Commun. 2021;12:5454 pubmed publisher
  32. Ma M, Li G, Qi M, Jiang W, Zhou R. Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma. Front Immunol. 2021;12:718779 pubmed publisher
  33. Félix I, Jokela H, Karhula J, Kotaja N, Savontaus E, Salmi M, et al. Single-Cell Proteomics Reveals the Defined Heterogeneity of Resident Macrophages in White Adipose Tissue. Front Immunol. 2021;12:719979 pubmed publisher
  34. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  35. Hoffman R, Huang S, Chalasani G, Vallejo A. Disparate Recruitment and Retention of Plasmacytoid Dendritic Cells to The Small Intestinal Mucosa between Young and Aged Mice. Aging Dis. 2021;12:1183-1196 pubmed publisher
  36. Forman R, Logunova L, Smith H, Wemyss K, Mair I, Boon L, et al. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages. PLoS Pathog. 2021;17:e1009768 pubmed publisher
  37. Funk K, Arutyunov A, Desai P, White J, Soung A, Rosen S, et al. Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis. Aging Cell. 2021;20:e13412 pubmed publisher
  38. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  39. Petermann M, Orfanos Z, Sellau J, Gharaibeh M, Lotter H, Fleischer B, et al. CCR2 Deficiency Impairs Ly6Clo and Ly6Chi Monocyte Responses in Orientia tsutsugamushi Infection. Front Immunol. 2021;12:670219 pubmed publisher
  40. Ortega Molina A, Lebrero Fernández C, Sanz A, Deleyto Seldas N, Plata Gómez A, Menéndez C, et al. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Rep. 2021;36:109372 pubmed publisher
  41. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  42. Al Zaeed N, Budai Z, Szondy Z, Sarang Z. TAM kinase signaling is indispensable for proper skeletal muscle regeneration in mice. Cell Death Dis. 2021;12:611 pubmed publisher
  43. Nakatani T, Tsujimoto K, Park J, Jo T, Kimura T, Hayama Y, et al. The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II. Nat Commun. 2021;12:3333 pubmed publisher
  44. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  45. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  46. Oikonomou N, Schuijs M, Chatzigiagkos A, Androulidaki A, Aidinis V, Hammad H, et al. Airway epithelial cell necroptosis contributes to asthma exacerbation in a mouse model of house dust mite-induced allergic inflammation. Mucosal Immunol. 2021;14:1160-1171 pubmed publisher
  47. Clemen R, Freund E, Mrochen D, Miebach L, Schmidt A, Rauch B, et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. Adv Sci (Weinh). 2021;8:2003395 pubmed publisher
  48. Roca C, Burton O, Gergelits V, Prezzemolo T, Whyte C, Halpert R, et al. AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data. Nat Commun. 2021;12:2890 pubmed publisher
  49. McElrath C, Espinosa V, Lin J, Peng J, Sridhar R, Dutta O, et al. Critical role of interferons in gastrointestinal injury repair. Nat Commun. 2021;12:2624 pubmed publisher
  50. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  51. Lin T, Quellier D, Lamb J, Voisin T, Baral P, Bock F, et al. Pseudomonas aeruginosa-induced nociceptor activation increases susceptibility to infection. PLoS Pathog. 2021;17:e1009557 pubmed publisher
  52. Frenis K, Helmstädter J, Ruan Y, Schramm E, Kalinovic S, Kröller Schön S, et al. Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects. Basic Res Cardiol. 2021;116:31 pubmed publisher
  53. Jang S, Economides K, Moniz R, Sia C, Lewis N, McCoy C, et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biol. 2021;4:497 pubmed publisher
  54. Manrique Acevedo C, Padilla J, Naz H, Woodford M, Ghiarone T, Aroor A, et al. Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice. Front Physiol. 2021;12:588358 pubmed publisher
  55. Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  56. Chu A, Kok S, TSUI J, Lin M, Aguirre B, Wadehra M. Epithelial membrane protein 2 (Emp2) modulates innate immune cell population recruitment at the maternal-fetal interface. J Reprod Immunol. 2021;145:103309 pubmed publisher
  57. Voisin M, Shrestha E, Rollet C, Nikain C, Josefs T, Mahe M, et al. Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice. Commun Biol. 2021;4:420 pubmed publisher
  58. Beins E, Beiert T, Jenniches I, Hansen J, Leidmaa E, Schrickel J, et al. Cannabinoid receptor 1 signalling modulates stress susceptibility and microglial responses to chronic social defeat stress. Transl Psychiatry. 2021;11:164 pubmed publisher
  59. Okano J, Nakae Y, Nakagawa T, Katagi M, Terashima T, Nagakubo D, et al. A novel role for bone marrow-derived cells to recover damaged keratinocytes from radiation-induced injury. Sci Rep. 2021;11:5653 pubmed publisher
  60. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  61. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  62. Chen J, Cao X, Li B, Zhao Z, Chen S, Lai S, et al. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Front Immunol. 2020;11:621757 pubmed publisher
  63. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  64. Henrich I, Jain K, Young R, Quick L, Lindsay J, Park D, et al. Ubiquitin-specific protease 6 functions as a tumor suppressor in Ewing Sarcoma through immune activation. Cancer Res. 2021;: pubmed publisher
  65. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  66. Steele N, Biffi G, Kemp S, Zhang Y, Drouillard D, Syu L, et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Clin Cancer Res. 2021;: pubmed publisher
  67. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  68. da Silva R, Elizondo D, Brandy N, Haddock N, Boddie T, de Oliveira L, et al. Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses. Sci Rep. 2021;11:946 pubmed publisher
  69. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  70. Gurley J, Gmyrek G, McClellan M, Hargis E, Hauck S, Dozmorov M, et al. Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina. Invest Ophthalmol Vis Sci. 2020;61:19 pubmed publisher
  71. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  72. Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A. 2020;117:20159-20170 pubmed publisher
  73. Runyan C, Welch L, Lecuona E, Shigemura M, Amarelle L, Abdala Valencia H, et al. Impaired phagocytic function in CX3CR1+ tissue-resident skeletal muscle macrophages prevents muscle recovery after influenza A virus-induced pneumonia in old mice. Aging Cell. 2020;: pubmed publisher
  74. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher
  75. Bhaskar A, Kumar S, Khan M, Singh A, Dwivedi V, Nandicoori V. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. elife. 2020;9: pubmed publisher
  76. Svensson M, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody K, et al. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020;6:eaba4353 pubmed publisher
  77. Manils J, Webb L, Howes A, Janzen J, Boeing S, Bowcock A, et al. CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation. elife. 2020;9: pubmed publisher
  78. Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P, et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. elife. 2020;9: pubmed publisher
  79. Guyon C, Jmari N, Padonou F, Li Y, Ucar O, Fujikado N, et al. Aire-dependent genes undergo Clp1-mediated 3'UTR shortening associated with higher transcript stability in the thymus. elife. 2020;9: pubmed publisher
  80. LeBlang C, Medalla M, Nicoletti N, Hays E, Zhao J, Shattuck J, et al. Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy. Front Neurosci. 2020;14:285 pubmed publisher
  81. Dieterich L, Tacconi C, Menzi F, Proulx S, Kapaklikaya K, Hamada M, et al. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis. Angiogenesis. 2020;23:411-423 pubmed publisher
  82. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  83. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  84. Wuggenig P, Kaya B, Melhem H, Ayata C, Hruz P, Sayan A, et al. Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice. Commun Biol. 2020;3:130 pubmed publisher
  85. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  86. Clark D, Brazina S, Yang F, Hu D, Hsieh C, Niemi E, et al. Age-related changes to macrophages are detrimental to fracture healing in mice. Aging Cell. 2020;19:e13112 pubmed publisher
  87. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  88. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  89. Forbester J, Clement M, Wellington D, Yeung A, Dimonte S, Marsden M, et al. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models. J Virol. 2020;94: pubmed publisher
  90. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  91. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  92. Williams G, Marmion D, Schonhoff A, Jurkuvenaite A, Won W, Standaert D, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855-874 pubmed publisher
  93. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  94. Kimura S, Nakamura Y, Kobayashi N, Shiroguchi K, Kawakami E, Mutoh M, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11:234 pubmed publisher
  95. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  96. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  97. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  98. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  99. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  100. Brown C, Gudjonson H, Pritykin Y, Deep D, Lavallée V, Mendoza A, et al. Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity. Cell. 2019;179:846-863.e24 pubmed publisher
  101. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  102. Alspach E, Lussier D, Miceli A, Kizhvatov I, DuPage M, Luoma A, et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature. 2019;574:696-701 pubmed publisher
  103. Carpentier K, Davenport B, HAIST K, McCarthy M, May N, Robison A, et al. Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses. elife. 2019;8: pubmed publisher
  104. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  105. Lecocq Q, Zeven K, De Vlaeminck Y, Martens S, Massa S, Goyvaerts C, et al. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use. Biomolecules. 2019;9: pubmed publisher
  106. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  107. Zhang F, Parayath N, Ene C, Stephan S, Koehne A, Coon M, et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974 pubmed publisher
  108. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  109. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  110. Culemann S, Grüneboom A, Nicolás Ávila J, Weidner D, Lämmle K, Rothe T, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572:670-675 pubmed publisher
  111. Liu D, Yin X, Olyha S, Nascimento M, Chen P, White T, et al. IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection. Immunity. 2019;: pubmed publisher
  112. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  113. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  114. Loh J, Xu S, Huo J, Kim S, Wang Y, Lam K. Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity. J Clin Invest. 2019;129:2717-2729 pubmed publisher
  115. Persson E, Verstraete K, Heyndrickx I, Gevaert E, Aegerter H, Percier J, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science. 2019;364: pubmed publisher
  116. Garcia Agudo L, Janova H, Sendler L, Arinrad S, Steixner A, Hassouna I, et al. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion. FASEB J. 2019;33:8634-8647 pubmed publisher
  117. Sharma N, Vacher J, Allison J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019;116:10453-10462 pubmed publisher
  118. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  119. Kuriakose J, Redecke V, Guy C, Zhou J, Wu R, Ippagunta S, et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest. 2019;129:2251-2265 pubmed publisher
  120. Mogilenko D, Haas J, L homme L, Fleury S, Quemener S, Levavasseur M, et al. Metabolic and Innate Immune Cues Merge into a Specific Inflammatory Response via the UPR. Cell. 2019;177:1201-1216.e19 pubmed publisher
  121. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  122. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  123. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  124. Uderhardt S, Martins A, Tsang J, Lämmermann T, Germain R. Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage. Cell. 2019;177:541-555.e17 pubmed publisher
  125. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  126. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  127. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  128. Grootjans J, Krupka N, Hosomi S, Matute J, Hanley T, Saveljeva S, et al. Epithelial endoplasmic reticulum stress orchestrates a protective IgA response. Science. 2019;363:993-998 pubmed publisher
  129. Lavoie S, Conway K, Lassen K, Jijon H, Pan H, Chun E, et al. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. elife. 2019;8: pubmed publisher
  130. Chopin M, Lun A, Zhan Y, Schreuder J, Coughlan H, D Amico A, et al. Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT. Immunity. 2019;50:77-90.e5 pubmed publisher
  131. Düsedau H, Kleveman J, Figueiredo C, Biswas A, Steffen J, Kliche S, et al. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection-induced neuroinflammation. Glia. 2019;67:193-211 pubmed publisher
  132. Shishido T, Kohyama M, Nakai W, Matsumoto M, Miyata H, Suenaga T, et al. Invariant chain p41 mediates production of soluble MHC class II molecules. Biochem Biophys Res Commun. 2018;: pubmed publisher
  133. Al Mamun A, Yu H, Mirza M, Romana S, McCullough L, Liu F. Myeloid cell IRF4 signaling protects neonatal brains from hypoxic ischemic encephalopathy. Neurochem Int. 2019;127:148-157 pubmed publisher
  134. Normand S, Waldschmitt N, Neerincx A, Martinez Torres R, Chauvin C, Couturier Maillard A, et al. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens. Nat Commun. 2018;9:5338 pubmed publisher
  135. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  136. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  137. Benmerzoug S, Rose S, Bounab B, Gosset D, Duneau L, Chenuet P, et al. STING-dependent sensing of self-DNA drives silica-induced lung inflammation. Nat Commun. 2018;9:5226 pubmed publisher
  138. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  139. Uccellini M, Garcia Sastre A. ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes. Cell Rep. 2018;25:2784-2796.e3 pubmed publisher
  140. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  141. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  142. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  143. Paschalis E, Lei F, Zhou C, Kapoulea V, Dana R, Chodosh J, et al. Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes. Proc Natl Acad Sci U S A. 2018;115:E11359-E11368 pubmed publisher
  144. Theisen D, Davidson J, Briseño C, Gargaro M, Lauron E, Wang Q, et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018;362:694-699 pubmed publisher
  145. Choi H, Suwanpradid J, Kim I, Staats H, Haniffa M, Macleod A, et al. Perivascular dendritic cells elicit anaphylaxis by relaying allergens to mast cells via microvesicles. Science. 2018;362: pubmed publisher
  146. Bhagwandin C, Ashbeck E, Whalen M, Bandola Simon J, Roche P, Szajman A, et al. The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS ONE. 2018;13:e0204898 pubmed publisher
  147. Cabron A, El Azzouzi K, Boss M, Arnold P, Schwarz J, Rosas M, et al. Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells. J Immunol. 2018;201:3106-3118 pubmed publisher
  148. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  149. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  150. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  151. Qu J, Li L, Xie H, Zhang X, Yang Q, Qiu H, et al. TLR3 Modulates the Response of NK Cells against Schistosoma japonicum. J Immunol Res. 2018;2018:7519856 pubmed publisher
  152. Adam L, Lopez Gonzalez M, Björk A, Pålsson S, Poux C, Wahren Herlenius M, et al. Early Resistance of Non-virulent Mycobacterial Infection in C57BL/6 Mice Is Associated With Rapid Up-Regulation of Antimicrobial Cathelicidin Camp. Front Immunol. 2018;9:1939 pubmed publisher
  153. Giles D, Duncker P, Wilkinson N, Washnock Schmid J, Segal B. CNS-resident classical DCs play a critical role in CNS autoimmune disease. J Clin Invest. 2018;128:5322-5334 pubmed publisher
  154. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  155. Williams G, Schonhoff A, Jurkuvenaite A, Thome A, Standaert D, Harms A. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. J Neuroinflammation. 2018;15:244 pubmed publisher
  156. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  157. Ko Y, Chan Y, Liu C, Liang J, Chuang T, Hsueh Y, et al. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M. Front Immunol. 2018;9:1828 pubmed publisher
  158. Qian G, Jiang W, Zou B, Feng J, Cheng X, Gu J, et al. LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma. J Exp Med. 2018;215:2397-2412 pubmed publisher
  159. Wilson K, Liu H, Healey G, Vuong V, Ishido S, Herold M, et al. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway. PLoS ONE. 2018;13:e0200540 pubmed publisher
  160. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  161. Li J, Byrne K, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. 2018;49:178-193.e7 pubmed publisher
  162. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed publisher
  163. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  164. Napolitano A, van der Veen A, Bunyan M, Borg A, Frith D, Howell S, et al. Cysteine-Reactive Free ISG15 Generates IL-1β-Producing CD8α+ Dendritic Cells at the Site of Infection. J Immunol. 2018;201:604-614 pubmed publisher
  165. Luo N, Formisano L, Gonzalez Ericsson P, Sanchez V, Dean P, Opalenik S, et al. Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. Oncoimmunology. 2018;7:e1438106 pubmed publisher
  166. Montero Herradón S, García Ceca J, Zapata A. Altered Maturation of Medullary TEC in EphB-Deficient Thymi Is Recovered by RANK Signaling Stimulation. Front Immunol. 2018;9:1020 pubmed publisher
  167. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  168. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  169. Jun H, Yu H, Gong J, Jiang J, Qiao X, Perkey E, et al. An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling. Nat Med. 2018;24:814-822 pubmed publisher
  170. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  171. Kyung D, Sung H, Kim Y, Kim K, Cho S, Choi J, et al. Global transcriptome analysis identifies weight regain-induced activation of adaptive immune responses in white adipose tissue of mice. Int J Obes (Lond). 2018;42:755-764 pubmed publisher
  172. Thomson C, van de Pavert S, Stakenborg M, Labeeuw E, Matteoli G, Mowat A, et al. Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators. J Immunol. 2018;201:215-229 pubmed publisher
  173. Bellelli R, Borel V, Logan C, Svendsen J, Cox D, Nye E, et al. Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis. Mol Cell. 2018;70:707-721.e7 pubmed publisher
  174. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  175. Grist J, Marro B, Skinner D, Syage A, Worne C, Doty D, et al. Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. Eur J Immunol. 2018;48:1199-1210 pubmed publisher
  176. Singla B, Ghoshal P, Lin H, Wei Q, Dong Z, Csanyi G. PKCδ-Mediated Nox2 Activation Promotes Fluid-Phase Pinocytosis of Antigens by Immature Dendritic Cells. Front Immunol. 2018;9:537 pubmed publisher
  177. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  178. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  179. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  180. Yeh C, Nojima T, Kuraoka M, Kelsoe G. Germinal center entry not selection of B cells is controlled by peptide-MHCII complex density. Nat Commun. 2018;9:928 pubmed publisher
  181. Huang L, Nazarova E, Tan S, Liu Y, Russell D. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J Exp Med. 2018;215:1135-1152 pubmed publisher
  182. Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, et al. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. PLoS ONE. 2018;13:e0193737 pubmed publisher
  183. Panduro M, Benoist C, Mathis D. Treg cells limit IFN-? production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A. 2018;115:E2585-E2593 pubmed publisher
  184. Yang J, Cornelissen F, Papazian N, Reijmers R, Llorian M, Cupedo T, et al. IL-7-dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes. J Exp Med. 2018;215:1069-1077 pubmed publisher
  185. Zhu Y, Zhou J, Feng Y, Chen L, Zhang L, Yang F, et al. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. Front Immunol. 2018;9:87 pubmed publisher
  186. Liang W, Mao S, Sun S, Li M, Li Z, Yu R, et al. Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation. Front Immunol. 2018;9:78 pubmed publisher
  187. King E, Mazor R, Cuburu N, Pastan I. Low-Dose Methotrexate Prevents Primary and Secondary Humoral Immune Responses and Induces Immune Tolerance to a Recombinant Immunotoxin. J Immunol. 2018;200:2038-2045 pubmed publisher
  188. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  189. Soncin I, Sheng J, Chen Q, Foo S, Duan K, Lum J, et al. The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma. Nat Commun. 2018;9:582 pubmed publisher
  190. Kilgore A, Welsh S, Cheney E, Chitrakar A, Blain T, Kedl B, et al. IL-27p28 Production by XCR1+ Dendritic Cells and Monocytes Effectively Predicts Adjuvant-Elicited CD8+ T Cell Responses. Immunohorizons. 2018;2:1-11 pubmed publisher
  191. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  192. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  193. Leonardi I, Li X, Semon A, Li D, Doron I, Putzel G, et al. CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. Science. 2018;359:232-236 pubmed publisher
  194. Fletcher K, Ulferts R, Jacquin E, Veith T, Gammoh N, Arasteh J, et al. The WD40 domain of ATG16L1 is required for its non-canonical role in lipidation of LC3 at single membranes. EMBO J. 2018;37: pubmed publisher
  195. Choi I, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, et al. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc Natl Acad Sci U S A. 2018;115:E686-E695 pubmed publisher
  196. Lynch J, Werder R, Loh Z, Sikder M, Curren B, Zhang V, et al. Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion. J Exp Med. 2018;215:537-557 pubmed publisher
  197. Hogstad B, Berres M, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, et al. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med. 2018;215:319-336 pubmed publisher
  198. Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher
  199. Harms A, Thome A, Yan Z, Schonhoff A, Williams G, Li X, et al. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179-187 pubmed publisher
  200. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  201. Dehn S, Thorp E. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair. FASEB J. 2018;32:254-264 pubmed publisher
  202. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  203. Denzin L, Khan A, Virdis F, Wilks J, Kane M, Beilinson H, et al. Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob. Immunity. 2017;47:310-322.e7 pubmed publisher
  204. Hannibal T, Schmidt Christensen A, Nilsson J, Fransén Pettersson N, Hansen L, Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60:2033-2041 pubmed publisher
  205. Anderson D, Grajales Reyes G, Satpathy A, Vasquez Hueichucura C, Murphy T, Murphy K. Revisiting the specificity of the MHC class?II transactivator CIITA in classical murine dendritic cells in vivo. Eur J Immunol. 2017;47:1317-1323 pubmed publisher
  206. Dunst J, Azzouz N, Liu X, Tsukita S, Seeberger P, Kamena F. Interaction between Plasmodium Glycosylphosphatidylinositol and the Host Protein Moesin Has No Implication in Malaria Pathology. Front Cell Infect Microbiol. 2017;7:183 pubmed publisher
  207. Jinnohara T, Kanaya T, Hase K, Sakakibara S, Kato T, Tachibana N, et al. IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake. J Exp Med. 2017;214:1607-1618 pubmed publisher
  208. Minutti C, Jackson Jones L, Garcia Fojeda B, Knipper J, Sutherland T, Logan N, et al. Local amplifiers of IL-4R?-mediated macrophage activation promote repair in lung and liver. Science. 2017;356:1076-1080 pubmed publisher
  209. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  210. Acharya N, Penukonda S, Shcheglova T, Hagymasi A, Basu S, Srivastava P. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A. 2017;114:5005-5010 pubmed publisher
  211. Smith T, Moffett H, Stephan S, Opel C, Dumigan A, Jiang X, et al. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. J Clin Invest. 2017;127:2176-2191 pubmed publisher
  212. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  213. Shrestha B, You D, Saravia J, Siefker D, Jaligama S, Lee G, et al. IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. J Leukoc Biol. 2017;102:153-161 pubmed publisher
  214. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  215. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  216. Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250-254 pubmed publisher
  217. Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med. 2017;214:1181-1198 pubmed publisher
  218. Briseño C, Gargaro M, Durai V, Davidson J, Theisen D, Anderson D, et al. Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A. 2017;114:3957-3962 pubmed publisher
  219. Wang X, Chen H, Tian R, Zhang Y, Drutskaya M, Wang C, et al. Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF. Nat Commun. 2017;8:14091 pubmed publisher
  220. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed publisher
  221. Hauptmann M, Burkhardt N, Munderloh U, Kuehl S, Richardt U, Krasemann S, et al. GFPuv-Expressing Recombinant Rickettsia typhi: a Useful Tool for the Study of Pathogenesis and CD8+ T Cell Immunology in R. typhi Infection. Infect Immun. 2017;85: pubmed publisher
  222. Schuh E, Musumeci A, Thaler F, Laurent S, Ellwart J, Hohlfeld R, et al. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement. J Immunol. 2017;198:3081-3088 pubmed publisher
  223. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  224. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  225. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  226. Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5 pubmed publisher
  227. Nicolas N, Michel V, Bhushan S, Wahle E, Hayward S, Ludlow H, et al. Testicular activin and follistatin levels are elevated during the course of experimental autoimmune epididymo-orchitis in mice. Sci Rep. 2017;7:42391 pubmed publisher
  228. Rossey I, Gilman M, Kabeche S, Sedeyn K, Wrapp D, Kanekiyo M, et al. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017;8:14158 pubmed publisher
  229. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  230. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed publisher
  231. Troegeler A, Mercier I, Cougoule C, Pietretti D, Colom A, Duval C, et al. C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells. Proc Natl Acad Sci U S A. 2017;114:E540-E549 pubmed publisher
  232. Yun T, Lee J, Shim D, Choi J, Cheong C. Isolation and Characterization of Aortic Dendritic Cells and Lymphocytes in Atherosclerosis. Methods Mol Biol. 2017;1559:419-437 pubmed publisher
  233. Scott C, Bain C, Mowat A. Isolation and Identification of Intestinal Myeloid Cells. Methods Mol Biol. 2017;1559:223-239 pubmed publisher
  234. Xue N, Zhou Q, Ji M, Jin J, Lai F, Chen J, et al. Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype. Sci Rep. 2017;7:39011 pubmed publisher
  235. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  236. Griffiths K, Ahmed M, Das S, Gopal R, Horne W, Connell T, et al. Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy. Nat Commun. 2016;7:13894 pubmed publisher
  237. Yasuda T, Ura T, Taniguchi M, Yoshida H. Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy. PLoS ONE. 2016;11:e0167952 pubmed publisher
  238. Herzig Y, Nevo S, Bornstein C, Brezis M, Ben Hur S, Shkedy A, et al. Transcriptional programs that control expression of the autoimmune regulator gene Aire. Nat Immunol. 2017;18:161-172 pubmed publisher
  239. Nakaya M, Watari K, Tajima M, Nakaya T, Matsuda S, Ohara H, et al. Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction. J Clin Invest. 2017;127:383-401 pubmed publisher
  240. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  241. Khameneh H, Ho A, Spreafico R, Derks H, Quek H, Mortellaro A. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol. 2017;198:196-204 pubmed
  242. Man A, Gicheva N, Regoli M, Rowley G, De Cunto G, Wellner N, et al. CX3CR1+ Cell-Mediated Salmonella Exclusion Protects the Intestinal Mucosa during the Initial Stage of Infection. J Immunol. 2017;198:335-343 pubmed
  243. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher
  244. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  245. Hidaka T, Ogawa E, Kobayashi E, Suzuki T, Funayama R, Nagashima T, et al. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol. 2017;18:64-73 pubmed publisher
  246. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  247. Le Blon D, Guglielmetti C, Hoornaert C, Quarta A, Daans J, Dooley D, et al. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model. J Neuroinflammation. 2016;13:288 pubmed
  248. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed publisher
  249. Tafteh R, Abraham L, Seo D, Lu H, Gold M, Chou K. Real-time 3D stabilization of a super-resolution microscope using an electrically tunable lens. Opt Express. 2016;24:22959-22970 pubmed publisher
  250. Jirmo A, Daluege K, Happle C, Albrecht M, Dittrich A, Busse M, et al. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod). J Immunol. 2016;197:4219-4227 pubmed
  251. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed publisher
  252. Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. 2016;7:82289-82304 pubmed publisher
  253. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  254. Rantakari P, Jäppinen N, Lokka E, Mokkala E, Gerke H, Peuhu E, et al. Fetal liver endothelium regulates the seeding of tissue-resident macrophages. Nature. 2016;538:392-396 pubmed publisher
  255. Yashiro T, Hara M, Ogawa H, Okumura K, Nishiyama C. Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells. Sci Rep. 2016;6:34825 pubmed publisher
  256. Guglielmetti C, Le Blon D, Santermans E, Salas Perdomo A, Daans J, De Vocht N, et al. Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Glia. 2016;64:2181-2200 pubmed publisher
  257. Ippagunta S, Gangwar R, Finkelstein D, Vogel P, Pelletier S, Gingras S, et al. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function. Proc Natl Acad Sci U S A. 2016;113:E6162-E6171 pubmed
  258. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  259. Bernard Valnet R, Yshii L, Quériault C, Nguyen X, Arthaud S, Rodrigues M, et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A. 2016;113:10956-61 pubmed publisher
  260. Stock A, Hansen J, Sleeman M, McKenzie B, Wicks I. GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease. J Exp Med. 2016;213:1983-98 pubmed publisher
  261. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed publisher
  262. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  263. Kim K, Williams J, Wang Y, Ivanov S, Gilfillan S, Colonna M, et al. MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytes. J Exp Med. 2016;213:1951-9 pubmed publisher
  264. Murakami S, Shahbazian D, Surana R, Zhang W, Chen H, Graham G, et al. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene. 2017;36:1232-1244 pubmed publisher
  265. Kouwenberg M, Jacobs C, van der Vlag J, Hilbrands L. Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. PLoS ONE. 2016;11:e0159986 pubmed publisher
  266. Achuthan A, Cook A, Lee M, Saleh R, Khiew H, Chang M, et al. Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation. J Clin Invest. 2016;126:3453-66 pubmed publisher
  267. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  268. Meliopoulos V, Van De Velde L, Van De Velde N, Karlsson E, Neale G, Vogel P, et al. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens. PLoS Pathog. 2016;12:e1005804 pubmed publisher
  269. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed publisher
  270. Boucard Jourdin M, Kugler D, Endale Ahanda M, This S, De Calisto J, Zhang A, et al. ?8 Integrin Expression and Activation of TGF-? by Intestinal Dendritic Cells Are Determined by Both Tissue Microenvironment and Cell Lineage. J Immunol. 2016;197:1968-78 pubmed publisher
  271. Yoshioka D, Kajiwara C, Ishii Y, Umeki K, Hiramatsu K, Kadota J, et al. Efficacy of ?-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. Antimicrob Agents Chemother. 2016;60:6146-54 pubmed publisher
  272. Schneider C, Nobs S, Heer A, Hirsch E, Penninger J, Siggs O, et al. Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection. J Leukoc Biol. 2017;101:367-376 pubmed publisher
  273. Xiao Y, Tang J, Guo H, Zhao Y, Tang R, Ouyang S, et al. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat Med. 2016;22:906-14 pubmed publisher
  274. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  275. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  276. Iwasaki Y, Sugita S, Mandai M, Yonemura S, Onishi A, Ito S, et al. Differentiation/Purification Protocol for Retinal Pigment Epithelium from Mouse Induced Pluripotent Stem Cells as a Research Tool. PLoS ONE. 2016;11:e0158282 pubmed publisher
  277. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  278. Ricard C, Tchoghandjian A, Luche H, Grenot P, Figarella Branger D, Rougon G, et al. Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice. Sci Rep. 2016;6:26381 pubmed publisher
  279. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  280. Nieves W, Hung L, Oniskey T, Boon L, Foretz M, Viollet B, et al. Myeloid-Restricted AMPK?1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. J Immunol. 2016;196:4632-40 pubmed publisher
  281. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  282. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  283. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  284. Hull T, Boddu R, Guo L, Tisher C, Traylor A, Patel B, et al. Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight. 2016;1:e85817 pubmed
  285. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  286. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  287. Sim C, Cho Y, Kim B, Baek I, Kim Y, Lee M. 2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons. Cancer Immunol Immunother. 2016;65:663-75 pubmed publisher
  288. Hua J, Stevenson W, Dohlman T, Inomata T, Tahvildari M, Calcagno N, et al. Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 2016;57:1457-67 pubmed publisher
  289. Gomez de Agüero M, Ganal Vonarburg S, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-302 pubmed publisher
  290. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  291. Xiao J, Shao L, Shen J, Jiang W, Feng Y, Zheng P, et al. Effects of ketanserin on experimental colitis in mice and macrophage function. Int J Mol Med. 2016;37:659-68 pubmed publisher
  292. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  293. Levit Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity P, Rajewsky K, et al. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol. 2016;196:2348-60 pubmed publisher
  294. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  295. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  296. Naujoks J, Tabeling C, Dill B, Hoffmann C, Brown A, Kunze M, et al. IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid. PLoS Pathog. 2016;12:e1005408 pubmed publisher
  297. Megías J, Martínez A, Yáñez A, Goodridge H, Gozalbo D, Gil M. TLR2, TLR4 and Dectin-1 signalling in hematopoietic stem and progenitor cells determines the antifungal phenotype of the macrophages they produce. Microbes Infect. 2016;18:354-63 pubmed publisher
  298. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
  299. Foks A, Engelbertsen D, Kuperwaser F, Alberts Grill N, Gonen A, Witztum J, et al. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol. 2016;36:456-65 pubmed publisher
  300. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  301. Scott C, Zheng F, De Baetselier P, Martens L, Saeys Y, De Prijck S, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321 pubmed publisher
  302. Grabert K, Michoel T, Karavolos M, Clohisey S, Baillie J, Stevens M, et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016;19:504-16 pubmed publisher
  303. Tellier J, Shi W, Minnich M, Liao Y, Crawford S, Smyth G, et al. Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response. Nat Immunol. 2016;17:323-30 pubmed publisher
  304. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  305. Everts B, Tussiwand R, Dreesen L, Fairfax K, Huang S, Smith A, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016;213:35-51 pubmed publisher
  306. Connor A, Kelley P, Tempero R. Lymphatic endothelial lineage assemblage during corneal lymphangiogenesis. Lab Invest. 2016;96:270-82 pubmed publisher
  307. Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17:159-68 pubmed publisher
  308. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  309. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  310. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  311. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  312. Thome A, Standaert D, Harms A. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease. PLoS ONE. 2015;10:e0140566 pubmed publisher
  313. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  314. Wu V, Smith A, You H, Nguyen T, Ferguson R, Taylor M, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9:777-86 pubmed publisher
  315. Sun L, Sun C, Liang Z, Li H, Chen L, Luo H, et al. FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells. Sci Rep. 2015;5:14871 pubmed publisher
  316. Lammers K, Chieppa M, Liu L, Liu S, Omatsu T, Janka Junttila M, et al. Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1. PLoS ONE. 2015;10:e0138338 pubmed publisher
  317. Brasseit J, Althaus Steiner E, Faderl M, Dickgreber N, Saurer L, Genitsch V, et al. CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis. Mucosal Immunol. 2016;9:689-701 pubmed publisher
  318. Hanot Mambres D, Machelart A, Vanderwinden J, De Trez C, Ryffel B, Letesson J, et al. In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice. PLoS ONE. 2015;10:e0137835 pubmed publisher
  319. Castillo V, Oñate M, Woehlbier U, Rozas P, Andreu C, Medinas D, et al. Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration. PLoS ONE. 2015;10:e0136620 pubmed publisher
  320. Martin Blondel G, Pignolet B, Tietz S, Yshii L, Gebauer C, Périnat T, et al. Migration of encephalitogenic CD8 T cells into the central nervous system is dependent on the α4β1-integrin. Eur J Immunol. 2015;45:3302-12 pubmed publisher
  321. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  322. Ermert D, Shaughnessy J, Joeris T, Kaplan J, Pang C, Kurt Jones E, et al. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors. PLoS Pathog. 2015;11:e1005043 pubmed publisher
  323. Glennon E, Kaunzner U, Gagnidze K, McEwen B, Bulloch K. Pituitary dendritic cells communicate immune pathogenic signals. Brain Behav Immun. 2015;50:232-240 pubmed publisher
  324. Kratochvill F, Gratz N, Qualls J, Van De Velde L, Chi H, Kovarik P, et al. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner. Cancer Res. 2015;75:3054-64 pubmed publisher
  325. Pérez Girón J, Gómez Medina S, Lüdtke A, Munoz Fontela C. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. J Vis Exp. 2015;:e52803 pubmed publisher
  326. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  327. Louveau A, Smirnov I, Keyes T, Eccles J, Rouhani S, Peske J, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337-41 pubmed publisher
  328. Teo T, Her Z, Tan J, Lum F, Lee W, Chan Y, et al. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol. 2015;89:7955-69 pubmed publisher
  329. Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson A, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522:349-53 pubmed publisher
  330. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  331. Becker P, Hervouet C, Mason G, KWON S, Klavinskis L. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. 2015;33:4691-8 pubmed publisher
  332. Dahlgren M, Gustafsson Hedberg T, Livingston M, Cucak H, Alsén S, Yrlid U, et al. T follicular helper, but not Th1, cell differentiation in the absence of conventional dendritic cells. J Immunol. 2015;194:5187-99 pubmed publisher
  333. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  334. Rozanski C, Utley A, Carlson L, Farren M, Murray M, Russell L, et al. CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif. J Immunol. 2015;194:4717-28 pubmed publisher
  335. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed publisher
  336. Wong E, Soni C, Chan A, Domeier P, Shwetank -, Abraham T, et al. B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance. J Immunol. 2015;194:4130-43 pubmed publisher
  337. Watanabe S, Chan K, Wang J, Rivino L, Lok S, Vasudevan S. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. J Virol. 2015;89:5847-61 pubmed publisher
  338. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  339. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  340. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  341. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  342. Haag S, Tuncel J, Thordardottir S, Mason D, Yau A, Dobritzsch D, et al. Positional identification of RT1-B (HLA-DQ) as susceptibility locus for autoimmune arthritis. J Immunol. 2015;194:2539-50 pubmed publisher
  343. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  344. Michelet X, Garg S, Wolf B, Tuli A, Ricciardi Castagnoli P, Brenner M. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. J Immunol. 2015;194:2079-88 pubmed publisher
  345. Karsten C, Laumonnier Y, Eurich B, Ender F, Bröker K, Roy S, et al. Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse. J Immunol. 2015;194:1841-55 pubmed publisher
  346. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed publisher
  347. Dewas C, Chen X, Honda T, Junttila I, Linton J, Udey M, et al. TSLP expression: analysis with a ZsGreen TSLP reporter mouse. J Immunol. 2015;194:1372-80 pubmed publisher
  348. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  349. Evrard M, Chong S, Devi S, Chew W, Lee B, Poidinger M, et al. Visualization of bone marrow monocyte mobilization using Cx3cr1gfp/+Flt3L-/- reporter mouse by multiphoton intravital microscopy. J Leukoc Biol. 2015;97:611-9 pubmed publisher
  350. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  351. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  352. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  353. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  354. Hou J, Zhang Q, Fujino M, Cai S, Ito H, Takahashi K, et al. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells. J Heart Lung Transplant. 2015;34:254-63 pubmed publisher
  355. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  356. Nakamura M, Shibata K, Hatano S, Sato T, Ohkawa Y, Yamada H, et al. A genome-wide analysis identifies a notch-RBP-Jκ-IL-7Rα axis that controls IL-17-producing γδ T cell homeostasis in mice. J Immunol. 2015;194:243-51 pubmed publisher
  357. van Blijswijk J, Schraml B, Rogers N, Whitney P, Zelenay S, Acton S, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307-15 pubmed publisher
  358. Lieber S, Scheer F, Finkernagel F, Meissner W, Giehl G, Brendel C, et al. The inverse agonist DG172 triggers a PPARβ/δ-independent myeloid lineage shift and promotes GM-CSF/IL-4-induced dendritic cell differentiation. Mol Pharmacol. 2015;87:162-73 pubmed publisher
  359. Lee J, Dang X, Borboa A, Coimbra R, Baird A, Eliceiri B. Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation. Neuro Oncol. 2015;17:685-96 pubmed publisher
  360. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  361. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  362. Jain R, Gray D. Isolation of thymic epithelial cells and analysis by flow cytometry. Curr Protoc Immunol. 2014;107:3.26.1-15 pubmed publisher
  363. Morales D, Monte K, Sun L, Struckhoff J, Agapov E, Holtzman M, et al. Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice. J Virol. 2015;89:337-49 pubmed publisher
  364. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  365. Becker A, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Exp Hematol. 2015;43:44-52.e1-3 pubmed publisher
  366. Xia H, Ren X, Bolte C, Ustiyan V, Zhang Y, Shah T, et al. Foxm1 regulates resolution of hyperoxic lung injury in newborns. Am J Respir Cell Mol Biol. 2015;52:611-21 pubmed publisher
  367. Nagano T, Edamatsu H, Kobayashi K, Takenaka N, Yamamoto M, Sasaki N, et al. Phospholipase cε, an effector of ras and rap small GTPases, is required for airway inflammatory response in a mouse model of bronchial asthma. PLoS ONE. 2014;9:e108373 pubmed publisher
  368. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed publisher
  369. Cremasco V, Woodruff M, Onder L, Cupovic J, Nieves Bonilla J, Schildberg F, et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol. 2014;15:973-81 pubmed publisher
  370. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  371. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  372. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  373. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  374. Madireddi S, Eun S, Lee S, Nemčovičová I, Mehta A, Zajonc D, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med. 2014;211:1433-48 pubmed publisher
  375. Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika A, et al. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci. 2014;34:8175-85 pubmed publisher
  376. Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56 pubmed publisher
  377. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  378. Leppin K, Behrendt A, Reichard M, Stachs O, Guthoff R, Baltrusch S, et al. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea. Invest Ophthalmol Vis Sci. 2014;55:3603-15 pubmed publisher
  379. Sheng K, Herrero L, Taylor A, Hapel A, Mahalingam S. IL-3 and CSF-1 interact to promote generation of CD11c+ IL-10-producing macrophages. PLoS ONE. 2014;9:e95208 pubmed publisher
  380. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  381. König S, Nitzki F, Uhmann A, Dittmann K, Theiss Suennemann J, Herrmann M, et al. Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice. PLoS ONE. 2014;9:e93555 pubmed publisher
  382. Martins K, Steffens J, Van Tongeren S, Wells J, Bergeron A, Dickson S, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS ONE. 2014;9:e89735 pubmed publisher
  383. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher
  384. Schneppenheim J, Hüttl S, Mentrup T, Lüllmann Rauch R, Rothaug M, Engelke M, et al. The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo. Mol Cell Biol. 2014;34:1398-411 pubmed publisher
  385. Weber B, Schuster S, Zysset D, Rihs S, Dickgreber N, Schürch C, et al. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance. PLoS Pathog. 2014;10:e1003900 pubmed publisher
  386. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed publisher
  387. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  388. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  389. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  390. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  391. Cavnar M, Zeng S, Kim T, Sorenson E, Ocuin L, Balachandran V, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med. 2013;210:2873-86 pubmed publisher
  392. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed publisher
  393. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  394. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  395. Satpathy A, Briseño C, Lee J, Ng D, Manieri N, Kc W, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol. 2013;14:937-48 pubmed publisher
  396. Stoilova B, Kowenz Leutz E, Scheller M, Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBP? structure and post-translational modifications. PLoS ONE. 2013;8:e65169 pubmed publisher
  397. Redecke V, Wu R, Zhou J, Finkelstein D, Chaturvedi V, High A, et al. Hematopoietic progenitor cell lines with myeloid and lymphoid potential. Nat Methods. 2013;10:795-803 pubmed publisher
  398. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  399. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  400. Donat U, Weibel S, Hess M, Stritzker J, Härtl B, Sturm J, et al. Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice. PLoS ONE. 2012;7:e45942 pubmed publisher
  401. Botelho F, Bauer C, Finch D, Nikota J, Zavitz C, Kelly A, et al. IL-1?/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice. PLoS ONE. 2011;6:e28457 pubmed publisher
  402. Ferret Bernard S, Castro Borges W, Dowle A, Sanin D, Cook P, Turner J, et al. Plasma membrane proteomes of differentially matured dendritic cells identified by LC-MS/MS combined with iTRAQ labelling. J Proteomics. 2012;75:938-48 pubmed publisher
  403. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  404. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  405. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  406. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  407. Blache C, Adriouch S, Calbo S, Drouot L, Dulauroy S, Arnoult C, et al. Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. J Immunol. 2009;183:4182-6 pubmed publisher
  408. Carlow D, Gold M, Ziltener H. Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells. J Immunol. 2009;183:1155-65 pubmed publisher
  409. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  410. Tambuyzer B, Bergwerf I, De Vocht N, Reekmans K, Daans J, Jorens P, et al. Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol. 2009;87:267-73 pubmed publisher
  411. Blumenthal A, Kobayashi T, Pierini L, Banaei N, Ernst J, Miyake K, et al. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe. 2009;5:35-46 pubmed publisher
  412. Waskow C, Liu K, Darrasse Jèze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9:676-83 pubmed publisher
  413. Ikehara Y, Shiuchi N, Kabata Ikehara S, Nakanishi H, Yokoyama N, Takagi H, et al. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells. Cancer Lett. 2008;260:137-45 pubmed
  414. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349-62 pubmed
  415. van der Marel A, Samsom J, Greuter M, van Berkel L, O Toole T, Kraal G, et al. Blockade of IDO inhibits nasal tolerance induction. J Immunol. 2007;179:894-900 pubmed
  416. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott H, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007;8:304-11 pubmed
  417. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol. 2006;17:3028-40 pubmed
  418. Sato K, Imai Y, Higashi N, Kumamoto Y, Mukaida N, Irimura T. Redistributions of macrophages expressing the macrophage galactose-type C-type lectin (MGL) during antigen-induced chronic granulation tissue formation. Int Immunol. 2005;17:559-68 pubmed
  419. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed